SESSION TITLE: Diffuse Lung Disease
SESSION TYPE: Case Report Poster
PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM
INTRODUCTION: Pneumonitis is a major side-effect induced by Bleomycin therapeutic use, known as Bleomycin induced Peumonitis (BIP). Its clinical course resembles mainly to community acquired pneumonia (CAP). Various risk factors have been associated with BIP development and they are considered as crucial for its incidence. Steroids are widely used for BIP therapy.